Publicacións (67) Publicacións de Francisco Javier López González

2023

  1. Donepezil alone and combined with intensive language-action therapy on depression and apathy in chronic post-stroke aphasia: A feasibility study

    Brain and Language, Vol. 236

  2. Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review

    Movement Disorders Clinical Practice, Vol. 10, Núm. 11, pp. 1671-1679

  3. La señal de la cruz: un automatismo muy poco frecuente en la epilepsia del lóbulo temporal. Descripción de dos casos

    Revista de neurologia, Vol. 77, Núm. 4, pp. 105-108

  4. Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Epilepsia Open, Vol. 8, Núm. 3, pp. 918-929

  5. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

    Epilepsy and Behavior, Vol. 145

2022

  1. Impact of spill-in counts from off-target regions on [18F]Flortaucipir PET quantification

    NeuroImage, Vol. 259

  2. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

2021

  1. Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente

    Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268

  2. New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol

    Revista de Neurologia, Vol. 72, pp. S1-S10

  3. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study

    Epilepsy Research, Vol. 172

  4. SimPET—An open online platform for the Monte Carlo simulation of realistic brain PET data. Validation for 18F-FDG scans

    Medical Physics, Vol. 48, Núm. 5, pp. 2482-2493

2020

  1. Consensus statement for the management of generalized tonic-clonic seizures in Spain

    Acta Neurologica Scandinavica, Vol. 141, Núm. 1, pp. 22-32

  2. Intensity normalization methods in brain FDG-PET quantification

    NeuroImage, Vol. 222

  3. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations

    Neurologia, Vol. 35, Núm. 2, pp. 115-125

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

  3. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

  4. Need to Know" or the Strong Urge to Find Names of Unique Entities in Acquired Obsessive-Compulsive Disorder

    Cognitive and Behavioral Neurology, Vol. 32, Núm. 2, pp. 124-133

  5. QModeling: a Multiplatform, Easy-to-Use and Open-Source Toolbox for PET Kinetic Analysis

    Neuroinformatics, Vol. 17, Núm. 1, pp. 103-114

  6. Use of intravenous brivaracetam in status epilepticus: A multicenter registry

    Epilepsia, Vol. 60, Núm. 8, pp. 1593-1601